宫缩抑制剂对胎膜早破早产儿结局的影响

目的对应用宫缩抑制剂对胎膜早破现象进行治疗后对早产新生儿结局的影响进行研究分析。方法选取78例胎膜早破产妇病例资料,将其分为对照组和治疗组,各39例。对照组进行常规治疗和处理,治疗组在对照组基础上加用宫缩抑制剂。对两组新生儿体重、不良事件发生率、Apgar评分情况进行对比。结果治疗组新生儿体重(2357.2±208.3)g明显高于对照组(1952.4±184.7)g,Apgar评分(8.6±0.8)分明显大于对照组(6.7±1.1)分,出现不良事件的人数明显少于对照组。结论应用宫缩抑制剂对胎膜早破现象进行治疗后可使新生儿结局更加理想,可以有效防止新生儿在围产期内出现各类不良事件,使新生儿的体重和Apgar评分水平进一步提高。

Objective Application of tocolytic agents on Prom phenomenon after treatment of the premature newborn outcome analysis. Methods 78 cases of premature rupture of membranes from maternal case information, which can be divided into control group and treatment group,39 cases in each group the average. The control group was given conventional treatment and processing; the treatment group in the control group based on the use of tocolytic agents. On two groups of newborn weight, the incidence of adverse events, Apgar score were contrast. Results The treatment group （2357.2±208.3）neonatal body weight of G was significantly higher than that in control group （1952.4±184.7）g;Apgar score （8.6±0.8）were significantly greater than in the control group （6.7±1.1）;adverse events were fewer than those in control group. Conclusion The application of tocolytic agents on Prom phenomenon after treatment can make the neonatal outcome is more ideal,can effectively prevent the newborn during perinatal period in all kinds of adverse events, the neonatal weight and Apgar score level rises further.